Sobi(TM) announces commercial launch of Elocta® in first countries in Europe

Swedish Orphan Biovitrum AB announced the commercial launch of Elocta® in first countries in Europe

Source: Pharmacy Europe - January 11, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Haematology Patient care elocta haemophilia a Latest News recombinant human factor VIII Fc fusion protein Source Type: news